CLDI logo

Calidi Biotherapeutics (CLDI) Cash From Financing

Annual CFF

$29.04 M
+$16.96 M+140.29%

December 31, 2023


Summary


Performance

CLDI Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

Quarterly CFF

$6.05 M
+$846.00 K+16.27%

September 30, 2024


Summary


Performance

CLDI Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

TTM CFF

$11.30 M
-$15.59 M-57.97%

September 30, 2024


Summary


Performance

CLDI TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CLDI Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+140.3%-72.1%-64.7%
3 y3 years+518.4%-72.1%-64.7%
5 y5 years+518.4%-72.1%-64.7%

CLDI Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+196.1%-72.1%+304.4%-64.7%+45.5%
5 y5-yearat high+518.4%-72.1%+304.4%-64.7%+45.5%
alltimeall timeat high+518.4%-72.1%+304.4%-64.7%+45.5%

Calidi Biotherapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$6.05 M(+16.3%)
$11.30 M(-58.0%)
Jun 2024
-
$5.20 M(+72.6%)
$26.89 M(-4.9%)
Mar 2024
-
$3.01 M(-201.9%)
$28.27 M(-2.7%)
Dec 2023
$29.04 M
-$2.96 M(-113.7%)
$29.04 M(-9.2%)
Sep 2023
-
$21.64 M(+229.1%)
$32.00 M(+76.5%)
DateAnnualQuarterlyTTM
Jun 2023
-
$6.58 M(+73.4%)
$18.13 M(+56.9%)
Mar 2023
-
$3.79 M(-51.2%)
$11.56 M(+48.8%)
Dec 2022
$12.09 M(+23.2%)
-
-
Sep 2022
-
$7.77 M
$7.77 M
Dec 2021
$9.81 M(+108.9%)
-
-
Dec 2020
$4.70 M
-
-

FAQ

  • What is Calidi Biotherapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics annual CFF year-on-year change?
  • What is Calidi Biotherapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics quarterly CFF year-on-year change?
  • What is Calidi Biotherapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics TTM CFF year-on-year change?

What is Calidi Biotherapeutics annual cash flow from financing activities?

The current annual CFF of CLDI is $29.04 M

What is the all time high annual CFF for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high annual cash flow from financing activities is $29.04 M

What is Calidi Biotherapeutics annual CFF year-on-year change?

Over the past year, CLDI annual cash flow from financing activities has changed by +$16.96 M (+140.29%)

What is Calidi Biotherapeutics quarterly cash flow from financing activities?

The current quarterly CFF of CLDI is $6.05 M

What is the all time high quarterly CFF for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high quarterly cash flow from financing activities is $21.64 M

What is Calidi Biotherapeutics quarterly CFF year-on-year change?

Over the past year, CLDI quarterly cash flow from financing activities has changed by -$15.59 M (-72.06%)

What is Calidi Biotherapeutics TTM cash flow from financing activities?

The current TTM CFF of CLDI is $11.30 M

What is the all time high TTM CFF for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high TTM cash flow from financing activities is $32.00 M

What is Calidi Biotherapeutics TTM CFF year-on-year change?

Over the past year, CLDI TTM cash flow from financing activities has changed by -$20.70 M (-64.69%)